iOnctura

Genive, Switzerland

iOnctura is a clinical-stage biotechnology company that specializes in developing treatments for cancer.

$85.7M raised

Jun 2024

Series B

Top Investors

Schroders CapitalInkefEuropean Innovation Council3B Future Health FundVI Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has iOnctura raised?

iOnctura has raised $85.7M in total funding. The most recent round was Series B. The last funding was announced in June 2024.

Who are iOnctura's investors?

iOnctura's investors include Schroders Capital, Inkef, European Innovation Council, 3B Future Health Fund, VI Partners.

Where is iOnctura headquartered?

iOnctura is headquartered in Genive, Switzerland.

What does iOnctura do?

iOnctura is a clinical-stage biotechnology company that specializes in developing treatments for cancer.

What stage is iOnctura at?

iOnctura is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 20, 2024.

MLA

"iOnctura — Funding & Investors." VCBacked, June 20, 2024, https://www.vcbacked.co/company/ionctura. Accessed June 4, 2026.

APA

VCBacked. (2024). iOnctura — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/ionctura

Wikipedia (cite web)

{{cite web |title=iOnctura — Funding & Investors |url=https://www.vcbacked.co/company/ionctura |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 20, 2024.